Clinical Trial Update: Safety and Efficacy of Bexagliflozin Compared to Sitagliptin as Add-on Therapy to Metformin in Type 2 Diabetes Subjects [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Bexagliflozin to Sitagliptin as add-on to metformin in type 2 diabetes completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Bexagliflozin (null)
• Sitagliptin (sitagliptin)
• metformin (metformin)

Snippet

Sponsor: Theracos | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2021-06-04